Newsroom

Newsroom

PEI Keynote Interview

Media Coverage

March 1, 2022
Strong partnerships are critical to developing businesses at scale throughout key markets in Europe, say Marco Herbst, Greg Laï, Christian Rochat and Eric Rouzier at Clayton, Dubilier & Rice
Call In Podcast Logo.

Media Coverage

February 24, 2022
Episode 10 of the Call In podcast features a conversation with Julian Francis, President and CEO of Beacon Building Products – the largest publicly traded distributor of roofing materials and complementary building products in the U.S. and Canada...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...
Covetrus: Vet with Dog.

Press Release

May 25, 2022
Covetrus® (NASDAQ: CVET) (“Covetrus” or the “Company”), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement pursuant to which funds affiliated with Clayton, Dubilier & Rice (“...
Vindi Banga at WEF.

Events

May 24, 2022
Vindi Banga, CD&R Operating Partner, spoke at the Davos conference hosted by the World Economic Forum. The panel, moderated by Andy Serwer, Editor-in-Chief of Yahoo Finance, focused on trends shaping M&A activity and included perspectives...
Robert Quarta.

Events

May 20, 2022
CD&R Europe Chairman Roberto Quarta this week spoke to Peter Pfister, Private Markets Advisor, at the 2022 European Private Equity and Secondaries Investor Summit. In his keynote interview, “Differentiation in an Uncertain Market”, Mr. Quarta...
Cynosure News Image.

Press Release

May 17, 2022
Cynosure, LLC, a leader in medical aesthetics systems and technologies, announced today a new investment of $60 million from lead investor Clayton, Dubilier & Rice. The new capital supports the company's plans to continue investing ahead of...
Nadav Tomer Headshot.

Press Release

May 3, 2022
Clayton, Dubilier & Rice announced Nadav Tomer, a medical technology specialist, has been named an Operating Advisor to CD&R funds. Mr. Tomer will work with CD&R's healthcare team to help source new investments and advise the funds'...

Press Release

May 2, 2022
Vialto Partners today announced the completion of its sale from PwC to funds affiliated with Clayton, Dubilier & Rice (CD&R). Vialto Partners is a leading provider of globally integrated solutions supporting global workforce mobility,...
Humana Partnership Image.

Press Release

April 21, 2022
Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice (“CD&R”) to divest a majority interest in the Hospice and Personal Care divisions of Humana’s Kindred at...
Marta Benedek

Press Release

March 22, 2022
Clayton, Dubilier & Rice announced today that it has appointed Marta Benedek as European Director of the Portfolio Company Procurement Program. Ms. Benedek will work with the supply chain and procurement leaders at the Firm’s European portfolio...
Cornerstone Image.

Press Release

March 7, 2022
Cornerstone Building Brands, Inc. (NYSE: CNR) (“Cornerstone Building Brands” or the “Company”), the largest manufacturer of exterior building products in North America, today announced that it has entered into a definitive agreement to be acquired...
Simon Tinkler

Press Release

March 1, 2022
Clayton, Dubilier & Rice today announced that Simon Tinkler has been appointed as Senior Legal Advisor to CD&R LLP. In his new role, Mr. Tinkler will work closely with the European investment team to support CD&R LLP’s existing portfolio...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.